Enact Mortgage Insurance Enters into Quota Share Reinsurance Agreement
RALEIGH, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage […]
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to February 3, 2024
MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose […]
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage […]
Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director
Hong Kong, Jan. 03, 2024 (GLOBE NEWSWIRE) — Fenbo Holdings Limited (the “Company” or “Fenbo”), an established provider of personal […]
ChampionX Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
THE WOODLANDS, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that […]
Madrigal Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CONSHOHOCKEN, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics […]
Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
– On track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024 and Phase 2 results […]
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing […]
Global Mofy Metaverse Limited Announces the Closing of $10 Million Follow-on Offering
Beijing, CHINA, Jan. 03, 2024 (GLOBE NEWSWIRE) — Global Mofy Metaverse Limited (the “Company” or “Global Mofy Metaverse”) (NASDAQ: GMM), […]
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science […]
